# C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

> **NCT02134314** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 70 (actual)

## Conditions studied

- End Stage Renal Disease
- Kidney Failure
- Delayed Graft Function
- Ischemic Reperfusion Injury

## Interventions

- **DRUG:** C1 Esterase Inhibitor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02134314
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-03-13
- **Final completion:** 2017-03-13
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134314, "C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02134314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*